Evolution of the registration regulations for proprietary Chinese medicines in China

作     者：YUAN Lin WU Zhi-Ang SHAO Ming-Li YUAN Lin;WU Zhi-Ang;SHAO Ming-Li

作者机构：School of Business Administration Shenyang Pharmaceutical University Shenyang 110016 China 

出 版 物：《Chinese Journal of Natural Medicines》 (中国天然药物（英文版）)

年 卷 期：2017年第15卷第1期

页      面：4-11页

核心收录：

学科分类：1007[医学-药学(可授医学、理学学位)] 10[医学] 

主　　题：Registration Proprietary Chinese Medicine China 

摘      要：In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines(PCMs) in China over the past century by examining published literature and historical data. We will examine this evolving administrative practice for PCMs registration in China, which is divided to the following five stages:(1) initial measures(1915-1948);(2) early development(1949-1965);(3) provincial approval and trial implementation of the approval number system(1966-1984);(4) legislation and cleanup(1985-1999); and(5) centralized national approval(2000 until now), offering a panoramic view on the characteristics of PCMs registration management in China.